Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Norwalk Leslie V exercised options for 1,659 Neurocrine Biosciences, Inc. shares (Form 4)
Traded May 21, 2026 · Filed May 21, 2026
On May 21, 2026, Norwalk Leslie V (Director) exercised options for 1,659 Neurocrine Biosciences, Inc. shares, leaving 4,088 shares. Filed May 21, 2026 (Form 4).
- Options exercised
- 1,659 shares
- Holding after
- 4,088 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | Option exercise | 1,659 | 4,088 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Norwalk Leslie V
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Norwalk Leslie V · Jul 30, 2026
- Form 4 · Norwalk Leslie V · Jun 8, 2026
- Form 4 · Norwalk Leslie V · May 14, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026